Renal pathologist · Christie NHS Foundation Trust · United Kingdom (GB) · Nephrology
Data minimisation
Cadence target for Tier 2: 2 per year (assumption)
3 of 1 expected engagements
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 11 Sept 2026 | Medical education | Virtual | Dr. Anna Becker | Nephrada | Patient-reported outcomesAPRIL pathway mechanism+1 | 0 | — | Reviewed | ENG-0148 |
| 03 Aug 2026 | Congress meeting | Virtual | Dr. Anna Becker | Nephrada | APRIL pathway mechanism | 0 | — | Reviewed | ENG-0162 |
| 22 Jun 2026 | Scientific exchange | Virtual | Dr. Anna Becker | Nephrada | eGFR slope interpretationSteroid-sparing strategies+1 | 1 | — | Reviewed | ENG-0155 |
| 03 Feb 2026 | Congress meeting | Virtual | Dr. Anna Becker | Nephrada | APRIL pathway mechanismTreatment burden and fatigue+1 | 0 | — | Reviewed | ENG-0133 |
11 Sept 2026
Patient-reported outcomes, APRIL pathway mechanism, Treatment burden and fatigue
03 Aug 2026
APRIL pathway mechanism
22 Jun 2026
eGFR slope interpretation, Steroid-sparing strategies, Treatment burden and fatigue
03 Feb 2026
APRIL pathway mechanism, Treatment burden and fatigue, eGFR slope interpretation
Christie NHS Foundation Trust
Radiation oncologist
Oncology pharmacist
Community nephrologist
Community nephrologist
Renal pathologist
Academic nephrologist